The Medicine Maker | The Medicine Maker

Advancing Gene Therapy for Canavan Disease

November 11, 2025

Interim results from a clinical trial addressing a fatal brain matter disorder suggest that gene therapy could be an effective approach

3 min read

Bioprocessing

Smarter Cell Line Development for Better Biologics with AI

Drug manufacturing is under pressure as biologics become more complex. To simplify progress, cell line development is evolving with AI and automation.

Industry News

Promising Early Results in Solid Tumor Trial

Lyell Immunopharma acquires rights to CAR T cell therapy for solid tumors

Interviews

Malaria Vaccine Development: Oxford and ReciBioPharm Extend Manufacturing Deal

Expanded collaboration between Recipharm Advanced Bio and the UK’s University of Oxford targets vaccine candidates for malaria

Breaking Down the Data Walls

Pharma must break down data silos to power autonomy, speed, and improved product quality.

Cell & Gene Small Molecules Biopharma Future of Pharma

The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.

Our celebration of the most inspirational and influential leaders in medicine.

Find out more

Christine Allen

Professor, University of Toronto; Co-founder and CEO, Intrepid Labs

View Profile

Hanns-Christian Mahler

CEO (Chief Enablement Officer) & Board Member, ten23 health

View Profile

FOYA: Celebrating Innovation in Pharma Facilities

We interview Scott Billman, one of the judges of the ISPE Facility of the Year Awards, to learn more about the 2025 winners and the trends impacting facilities.

Read the article

All the latest Medicine Maker articles.

Cell & Gene

Roving Reporter Asks: What’s the Most Exciting Research in CGT?

November 7, 2025

Experts discuss in vivo CAR T cell therapy, gene therapies for CNS diseases, personalized cancer vaccines and more.

1 min read

Biopharma Cell & Gene Industry News

Integrity and Industry: Balancing Purpose and Profit

November 6, 2025

An invitation to our readers to feed back on our content

1 min read

Industry News

George Tidmarsh: FDA Resignation and Lawsuit

November 5, 2025

Tidmarsh reportedly resigns from FDA and Aurinia Pharmaceuticals files lawsuit

2 min read

Interviews Sitting Down With Cell & Gene Development & Clinical

From the Apollo Era to the World's First Cell Therapy: Sitting Down With Bruce Levine

November 5, 2025

Bruce Levine shares his journey from a childhood steeped in science to co-founding the first CAR T-cell trials, and explains why communication and regulatory collaboration are crucial for the field’s future.

7 min read

Outsourcing

Why ‘Good Enough’ is Not Acceptable in CRO Partnerships

November 5, 2025

Clinical trials are becoming more complex. And not all CROs are able to step up.

3 min read

Business & Trends Supply Chain

Supply Chains and the Next Black Swan Event

November 4, 2025

Are pharma logistics and supply chains ready for the next test?

8 min read

Interviews Business & Trends Bioprocessing Supply Chain

Overcoming the Static Sales Cycle

November 4, 2025

For decades, pharma sales strategies have been built on static lists and old data. Now, AI-driven models are replacing guesswork with live insights

8 min read

Cell & Gene

Roving Reporter Asks: What’s Your Tech Wishlist in CGT?

November 3, 2025

IBTV interviews 3 experts from the 2025 Cell & Gene Therapy Summit in London about advances in technology.

Cell & Gene Interviews Technology & Manufacturing

How To Optimize Batch Release for Advanced Therapies

November 3, 2025

For advanced therapies, every hour counts. The pressure on QA and QC teams is intense. How can automation ease the strain?

4 min read

Industry News Small Molecules Regulation & Standards

Securing Europe’s Antibiotic Supply: A More Functional Future

October 31, 2025

The latest New Angle report discusses the status of Europe’s antibiotics supply chain, and how structural reform at the policy level is required to rectify it.

3 min read

Top Stories